Cambongga, Estephanie O.
HRN: 28-71-36 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/20/2026
METRONIDAZOLE 500MG (TAB)
03/20/2026
03/27/2026
PO
500MG
Q8H
AMOEBIASIS
Pending Pharmacy Acceptance
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: